Abstract:
An information recording apparatus comprises a plurality of fine particles forming an array on a plane in close proximity of each other, each of the plural particles including a ferromagnetic metal, a light-emitting device for exciting a near-field light, and a photo-electric conversion element for detecting a near-field light traveled along the fine particles.
Abstract:
Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor.A compound represented by the formula: , its pharmaceutically acceptable salt, or a solvate thereof, wherein Ring A is a group represented by the formula: Ring B is optionally substituted heteroaryl, provided that optionally substituted isoxazole is excluded, or optionally substituted heterocycle, R1 is hydrogen or optionally substituted alkyl, R2 is —OR5, —SR5, halogen, halogenated alkyl or the like, R3 is optionally substituted alkyl or the like, R4 is optionally substituted alkyl or the like, R5 is optionally substituted alkyl or the like, R6 is hydrogen or the like, R7 and R8 are each independently hydrogen or the like, R10 and R11 are each independently hydrogen or the like, R12 is optionally substituted alkyl or the like, m and p are each independently integer of 1 to 3.
Abstract translation:公开了可用作11-羟基类固醇脱氢酶1型抑制剂的化合物。 由下式表示的化合物,其药学上可接受的盐或其溶剂合物,其中环A是下式表示的基团:环B是任选取代的杂芳基,条件是排除任选取代的异唑或任选取代的杂环,R 1 R 3为任选取代的烷基等,R 4为任选取代的烷基等,R 5为任选取代的烷基等,R 5为任选取代的烷基, R 6是氢等,R 7和R 8各自独立地为氢等,R 10和R 11各自独立地为氢等,R 12为任选取代的烷基等,m和p各自为1〜3的整数。
Abstract:
A compound represented by the general formula: wherein R20 is —CH2COOH and the like; R21 is —COCONH2 and the like; R22 is C4-C6 alkyl; and the like; R23 is —CH2—R18 wherein R18 is aryl and the like; R24 is hydrogen or C1-C6 alkyl and the like; an optical active compound, a prodrug thereof, or a pharmaceutically acceptable salt, or a solvate having type X sPLA2 inhibitory effect was found.
Abstract translation:由通式表示的化合物:其中R 20是-CH 2 COOH等; R 21是-COCONH 2等; R 22是C 4 -C 6烷基; 等等; R 23是-CH 2 -R 18,其中R 18是芳基等; R 24是氢或C 1 -C 6烷基等; 发现光学活性化合物,其前药,或其药学上可接受的盐,或具有X sPLA2型抑制作用的溶剂化物。
Abstract:
Disclosed is a compound useful as a type I 11βhydroxysteroid dehydrogenase inhibitor.A compound represented by the formula: a pharmaceutically acceptable salt or solvate thereof, wherein R1 is optionally substituted alkyl or the like, one of R2 and R4 is a group of formula: —Y—R5, wherein Y is —O— or the like, R5 is substituted alkyl (the substituent is optionally substituted cycloalkyl or the like), optionally substituted branched alkyl or the like, the other of R2 and R4 is hydrogen or optionally substituted alkyl, R3 is a group of formula: —C(═O)-Z-R6, wherein Z is —NR7— or —NR7—W—, R6 is optionally substituted cycloalkyl or the like, R7 is hydrogen or optionally substituted alkyl, W is optionally substituted alkylene, X is ═N— or the like, with the proviso that compounds wherein R2 is 2-(morphorino)ethoxy, R3 is N-(1-adamantyl)carbamoyl and R1 is benzyl are excluded.
Abstract:
An information recording apparatus comprises a plurality of fine particles forming an array on a plane in close proximity of each other, each of the plural particles including a ferromagnetic metal, a light-emitting device for exciting a near-field light, and a photo-electric conversion element for detecting a near-field light traveled along the fine particles.
Abstract:
A piezoelectric ceramic composition is expressed by the formula Pb&agr;[{Niw/3Nb1−(w/3)}xTiyZrz]O3. The B site variables x, y, and z lie in a predetermined region in a ternary diagram. The Ni—Nb molar proportion variable satisfies the relationship 0.85≦w
Abstract:
A piezoelectric ceramic composition contains a compound containing Na, Li, Nb and O, and having a perovskite structure, as a main component. The main component has a crystal phase in a semi-stable state at room temperature, such crystal phase originally not being stable at room temperature but being stable at a higher temperature.
Abstract:
A mobile communication base station antenna has a first array antenna and a second array antenna. Antenna elements of the first and second array antennas are classified into the first, second and third groups G1, G2 and G3. A first feeding port is connected to the antenna elements in the odd number groups (the first group G1 and the third group G3) of the first array antenna and the antenna elements in the even number group of the second array antenna. On the other hand, a second feeding port is connected to the antenna elements in the even number group (the second group G2) of the first array antenna and the antenna elements in the odd number groups (the first group G1 and the third group G3) of the second array antenna.
Abstract:
The present invention relates to ferromagnetic particles comprising an Fe16N2 compound phase in an amount of not less than 70% as measured by Mössbauer spectrum, and at least one metal element X selected from the group consisting of Mn, Ni, Ti, Ga, Al, Ge, Zn, Pt and Si in such an amount that a molar ratio of the metal element X to Fe is 0.04 to 25%, the ferromagnetic particles having a BHmax value of not less than 5 MGOe, and a process for producing the ferromagnetic particles, and further relates to an anisotropic magnet or a bonded magnet which is obtained by magnetically orienting the ferromagnetic particles. The ferromagnetic particles according to the present invention can be produced in an industrial scale and are in the form of Fe16N2 particles comprising different kinds of metal elements having a large BHmax value.
Abstract translation:本发明涉及由Mössbauer光谱测定的不少于70%的Fe 16 N 2化合物相和至少一种选自Mn,Ni,Ti,Ga,Al的金属元素X的铁磁性颗粒, Ge,Zn,Pt和Si,金属元素X与Fe的摩尔比为0.04〜25%,BHmax值为5MGOe以上的铁磁性粒子,以及铁磁性粒子的制造方法 并且还涉及通过磁性取向铁磁性颗粒获得的各向异性磁体或粘结磁体。 根据本发明的铁磁颗粒可以以工业规模生产,并且是包含具有大的BHmax值的不同种类的金属元素的Fe16N2颗粒的形式。
Abstract:
A method of purifying a cyclic ester, comprising: mixing a co-distillated liquid comprising a cyclic ester produced by heating depolymerization of a hydroxycarboxylic acid oligomer in the presence of a depolymerization solvent and the depolymerization solvent with an organic solvent for washing which is mutually soluble with the depolymerization solvent and has a lower boiling point than the cyclic ester; subjecting the resultant mixture liquid to liquid-liquid separation into an organic solvent phase containing the depolymerization solvent and a cyclic ester phase containing the organic solvent; and then evaporating the organic solvent from the cyclic ester phase containing the organic solvent to recover the cyclic ester containing a reduced amount of the depolymerization solvent. As a result, purified cyclic ester is recovered at high heat efficiency, purification efficiency and operation efficiency, from the co-distillate liquid containing the depolymerization solvent and the cyclic ester from the depolymerization system for thermal decomposition of the hydroxycarboxylic acid oligomer in the presence of the depolymerization solvent.